Acadia Pharmaceuticals
ACAD
ACAD
273 hedge funds and large institutions have $6.41B invested in Acadia Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 97 increasing their positions, 78 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
18% more funds holding
Funds holding: 231 → 273 (+42)
2% more call options, than puts
Call options by funds: $86.9M | Put options by funds: $85M
0.11% less ownership
Funds ownership: 97.32% → 97.22% (-0.11%)
Holders
273
Holding in Top 10
4
Calls
$86.9M
Puts
$85M
Top Buyers
| 1 | +$131M | |
| 2 | +$33.1M | |
| 3 | +$32.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$30.4M |
| 5 |
BlackRock
New York
|
+$30.4M |
Top Sellers
| 1 | -$111M | |
| 2 | -$79.4M | |
| 3 | -$47.1M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$40.2M |
| 5 |
D.E. Shaw & Co
New York
|
-$38.3M |